ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells

Experimental Cell Research

Volumn 324, Issue 2, 2014, Pages 137-145

  Machado Neto, João Agostinho ^a   Lazarini, Mariana ^a   Favaro, Patricia ^a,b   Franchi, Gilberto Carlos ^a   Nowill, Alexandre Eduardo ^a   Saad, Sara Teresinha Olalla ^a   Traina, Fabiola ^a,c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

ANKHD1; Cell cycle; Hippo pathway; MASK; Prostate cancer; YAP1

Indexed keywords

ANKYRIN; ANKYRIN REPEAT AND KH DOMAIN CONTAINING 1; CYCLIN A2; TRANSCRIPTION FACTOR YAP1; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; DOWN REGULATION; HUMAN; HUMAN CELL; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; TUMOR XENOGRAFT; UPREGULATION;

ANKHD1; CELL CYCLE; HIPPO PATHWAY; MASK; PROSTATE CANCER; YAP1;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CYCLIN A; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; K562 CELLS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; PHOSPHOPROTEINS; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84901194678     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.04.004     Document Type: Article

References (30)

1. Bao Y., Hata Y., Ikeda M., Withanage K. Mammalian Hippo pathway: from development to cancer and beyond. J. Biochem. 2011, 149:361-379.
2. Chan S.W., Lim C.J., Chen L., Chong Y.F., Huang C., et al. The Hippo pathway in biological control and cancer development. J. Cell Physiol. 2011, 226:928-939.
3. Komuro A., Nagai M., Navin N.E., Sudol M. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol. Chem. 2003, 278:33334-33341.
4. Espanel X., Sudol M. Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains. J. Biol. Chem. 2001, 276:14514-14523.
5. Zaidi S.K., Sullivan A.J., Medina R., Ito Y., van Wijnen A.J., et al. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J. 2004, 23:790-799.
6. Zhang L., Ren F., Zhang Q., Chen Y., Wang B., et al. The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev. Cell 2008, 14:377-387.
7. Wu S., Liu Y., Zheng Y., Dong J., Pan D. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev. Cell 2008, 14:388-398.
8. Lapi E., Di Agostino S., Donzelli S., Gal H., Domany E., et al. PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol. Cell 2008, 32:803-814.
9. Dong J., Feldmann G., Huang J., Wu S., Zhang N., et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130:1120-1133.
10. Overholtzer M., Zhang J., Smolen G.A., Muir B., Li W., et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl. Acad. Sci. USA 2006, 103:12405-12410.
11. Zhao B., Wei X., Li W., Udan R.S., Yang Q., et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007, 21:2747-2761.
12. Powzaniuk M., McElwee-Witmer S., Vogel R.L., Hayami T., Rutledge S.J., et al. The LATS2/KPM tumor suppressor is a negative regulator of the androgen receptor. Mol. Endocrinol. 2004, 18:2011-2023.
13. Poulin F., Brueschke A., Sonenberg N. Gene fusion and overlapping reading frames in the mammalian genes for 4E-BP3 and MASK. J. Biol. Chem. 2003, 278:52290-52297.
14. Sedgwick S.G., Smerdon S.J. The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem. Sci. 1999, 24:311-316.
15. Traina F., Favaro P.M., Medina Sde S., Duarte Ada S., Winnischofer S.M., et al. ANKHD1, ankyrin repeat and KH domain containing 1, is overexpressed in acute leukemias and is associated with SHP2 in K562 cells. Biochim. Biophys. Acta 2006, 1762:828-834.
16. Dhyani A., Duarte A.S., Machado-Neto J.A., Favaro P., Ortega M.M., et al. ANKHD1 regulates cell cycle progression and proliferation in multiple myeloma cells. FEBS Lett. 2012, 586:4311-4318.
17. Sansores-Garcia L., Atkins M., Moya I.M., Shahmoradgoli M., Tao C., et al. Mask is required for the activity of the Hippo pathway effector Yki/YAP. Curr.. Biol. 2013, 23:229-235.
18. Sidor C.M., Brain R., Thompson B.J. Mask proteins are cofactors of Yorkie/YAP in the Hippo pathway. Curr. Biol. 2013, 23:223-228.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
20. Favaro P., Traina F., Machado-Neto J.A., Lazarini M., Lopes M.R., et al. FMNL1 promotes proliferation and migration of leukemia cells. J. Leukoc. Biol. 2013, 94:503-512.
21. Ren Y.R., Patel K., Paun B.C., Kern S.E. Structural analysis of the cancer-specific promoter in mesothelin and in other genes overexpressed in cancers. J. Biol. Chem. 2011, 286:11960-11969.
22. Mizuno T., Murakami H., Fujii M., Ishiguro F., Tanaka I., et al. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes. Oncogene 2012, 31:5117-5122.
23. von Gise A., Lin Z., Schlegelmilch K., Honor L.B., Pan G.M., et al. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc. Natl. Acad. Sci. USA 2012, 109:2394-2399.
24. Liu A.M., Wong K.F., Jiang X., Qiao Y., Luk J.M. Regulators of mammalian Hippo pathway in cancer. Biochim. Biophys. Acta 1826, 2012:357-364.
25. Du Toit A. Cell signalling: a new Hippo pathway component. Nat. Rev. Mol. Cell Biol. 2013, 14:196.
26. Enderle L., McNeill H. Hippo gains weight: added insights and complexity to pathway control. Sci. Signal. 2013, 6:re7.
27. Kalaszczynska I., Geng Y., Iino T., Mizuno S., Choi Y., et al. Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells. Cell 2009, 138:352-365.
28. Geley S., Kramer E., Gieffers C., Gannon J., Peters J.M., et al. Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J. Cell Biol. 2001, 153:137-148.
29. McNeill H., Woodgett J.R. When pathways collide: collaboration and connivance among signalling proteins in development. Nat. Rev. Mol. Cell Biol. 2010, 11:404-413.
30. Fernandez L.A., Northcott P.A., Dalton J., Fraga C., Ellison D., et al. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev. 2009, 23:2729-2741.